Burning Rock Biotech
21 hedge funds and large institutions have $15.8M invested in Burning Rock Biotech in 2024 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
137% more capital invested
Capital invested by funds: $6.69M → $15.8M (+$9.15M)
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
17% more funds holding
Funds holding: 18 → 21 (+3)
0.36% more ownership
Funds ownership: 2.49% → 2.85% (+0.36%)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CL
CRCM LP
San Francisco,
California
|
+$1.5M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$56.5K |
| 3 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
+$26.1K |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$3.69K |
| 5 |
Morgan Stanley
New York
|
+$1.38K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$130K |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$50.7K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$13K |
| 4 |
NAMA
Nikko Asset Management Americas
New York
|
-$12.3K |
| 5 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$12.3K |
BNR Hedge Fund Activity: Q4 2024 in Review
21 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Burning Rock Biotech (BNR) for Q4 2024, worth a combined $15.8M — up 137% from $6.69M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new BNR positions and 1 closed out — a net gain of 3 holders — while 4 added to existing stakes and 6 trimmed.
The largest buyer was CRCM LP, opening a new position worth an estimated $1.5M. The largest seller was Millennium Management, cutting an estimated $130K.
- 21 institutional investors held Burning Rock Biotech (BNR) as of Q4 2024, up from 18 in Q3 2024.
- Funds reported $15.8M of Burning Rock Biotech stock for Q4 2024, up 137% quarter-over-quarter.
- 4 funds opened new Burning Rock Biotech positions in Q4 2024 and 1 closed out, a net change of +3 holders.
- The largest Burning Rock Biotech buyer in Q4 2024 was CRCM LP, an estimated $1.5M added.
- The largest Burning Rock Biotech seller in Q4 2024 was Millennium Management, an estimated $130K sold.
Based on aggregated 13F filings for Q4 2024.